Tipranavir
Back to searchMolecule Structure
Scientific Name
Tipranavir
Description of the Drug
Tipranavir is a protease inhibitor used to treat HIV-1 resistant to more than 1 protease inhibitor.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB00932
http://www.drugbank.ca/drugs/DB00932
Brand Name(s)
Aptivus
Company Owner(s)
Boehringer Ingelheim Pharmaceuticals Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Human immunodeficiency virus type 1 protease | SINGLE PROTEIN | INHIBITOR | CHEMBL243 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL40629 | |
| WDI | DR9606551 | |
| DrugBank | DB00932 | |
| PubChem: Thomson Pharma | 14813794 | 14813793 |
| PubChem | 54682461 | |
| Nikkaji | J790.736B | |
| PDBe | TPV | |
| BindingDB | 50479982 | |
| EPA CompTox Dashboard | DTXSID6048622 | |
| DrugCentral | 3609 | |
| Brenda | 2316 | |
| ChemicalBook | CB9501005 | |
| GSRS | 6e0e021c-7b42-4e74-8315-4a3d7b1fea80 | |
| rxnorm | APTIVUS | TIPRANAVIR |
| PubChem: Drugs of the Future | 12015070 | |
| ChEBI | 63628 | |
| ZINC | ZINC000100016058 |
